Product DemonstrationsLife Sciences

Leveraging Purigen's ITP-based extraction @ MD Anderson Cancer Center

1 Sept 2022
Leveraging Purigen's ITP-based extraction @ MD Anderson Cancer Center

ABRF 2022 Technology Showcase with special guest speaker Dr. Jian Gu from the University of Texas, MD Anderson Cancer Center. This video discusses how the next-gen Ionic® Purification System enables pure nucleic acid extraction from FFPE samples using our proprietary charge-based isotachophoresis (ITP) technology.

About the company

Purigen Biosystems logo

Purigen Biosystems

Purigen Biosystems' transformative Ionic Purification System provides a hands-free solution for extracting, enriching and quantifying DNA and RNA from biological samples. Our proprietary approach uses isotachophoresis (ITP), an electric-field-driven technique for purifying, focusing, and/or separating species. The application of ITP to purify and quantify nucleic acids from complex biological samples was pioneered by Purigen co-founder, Stanford Professor Juan G. Santiago. The Ionic® Purification System is compatible with a range of samples including cells and FFPE. Purigen is proudly affliated with StartX Med, a Stanford-University-affliated nonprofit technology accelerator, and the California Life Sciences Institute’s (CLSI) FAST Advisory Program.

Ionic® Purification System

Purigen Biosystems

The Ionic® Purification System is a benchtop platform that provides automated extraction of DNA and RNA from biological samples. Using cutting-edge technology based on isotachophoresis, the Ionic system separates DNA and RNA freely in solution, without binding to or stripping nucleic acids from physical surfaces. The workflow is simple and efficient, while producing higher yields with higher purity, consistently and reliably.

(0)

Other videos from Purigen Biosystems

Links

Leveraging Purigen's ITP-based extraction @ MD Anderson Cancer Center